Cover
Cover - shares | 3 Months Ended | |
Mar. 31, 2020 | Jul. 02, 2021 | |
Cover [Abstract] | ||
Entity Registrant Name | APEX 11 INC. | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Amendment Flag | false | |
Entity Central Index Key | 0001578329 | |
Document Period End Date | Mar. 31, 2020 | |
Entity Incorporation, State or Country Code | DE | |
Entity File Number | 333-213197 | |
Entity Current Reporting Status | No | |
Entity Interactive Data Current | No | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | true | |
Entity Common Stock, Shares Outstanding | 21,534,014 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2020 |
CONDENSED BALANCE SHEETS (Unaud
CONDENSED BALANCE SHEETS (Unaudited) - USD ($) | Mar. 31, 2020 | Dec. 31, 2019 |
LIABILITIES | ||
Accrued expenses | $ 365 | |
Controlling stockholder payable | 770 | |
Total liabilities | 1,135 | |
STOCKHOLDERS' EQUITY (DEFICIENCY) | ||
Preferred stock; $.0001 par value; 5,000,000 shares authorized; none issued and outstanding | ||
Common stock; $.0001 par value; 100,000,000 shares authorized; 21,534,014 issued and outstanding, respectively | 2,153 | 2,153 |
Additional paid-in capital | 67,750 | 67,750 |
Accumulated deficit | (71,038) | (69,903) |
Total stockholders' equity (deficiency) | (1,135) | |
Total liabilities and stockholders' equity (deficiency) |
CONDENSED BALANCE SHEETS (Una_2
CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares | Mar. 31, 2020 | Dec. 31, 2019 |
Statement of Financial Position [Abstract] | ||
Preferred stock par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 21,534,014 | 21,534,014 |
Common stock, shares outstanding | 21,534,014 | 21,534,014 |
CONDENSED STATEMENTS OF OPERATI
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
OPERATING EXPENSES | ||
General and administrative | $ 1,135 | $ 1,117 |
NET LOSS | $ (1,135) | $ (1,117) |
Basic and diluted loss per common share (in dollars per share) | $ 0 | $ 0 |
Basic and diluted weighted-average common shares outstanding (in shares) | 15,663,344 | 15,647,216 |
CONDENSED STATEMENTS OF STOCKHO
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIENCY) (UNAUDITED) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] | Total |
Balance at beginning at Dec. 31, 2018 | $ 1,565 | $ 41,307 | $ (41,906) | $ 966 |
Balance at beginning (in shares) at Dec. 31, 2018 | 15,647,216 | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Net loss | (1,117) | (1,117) | ||
Balance at ending at Mar. 31, 2019 | $ 1,565 | 41,307 | (43,023) | (151) |
Balances at ending (in shares) at Mar. 31, 2019 | 15,647,216 | |||
Balance at beginning at Dec. 31, 2019 | $ 2,153 | 67,750 | (69,903) | |
Balance at beginning (in shares) at Dec. 31, 2019 | 21,534,014 | 21,534,014 | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Net loss | (1,135) | $ (1,135) | ||
Balance at ending at Mar. 31, 2020 | $ 2,153 | $ 67,750 | $ (71,038) | $ (1,135) |
Balances at ending (in shares) at Mar. 31, 2020 | 21,534,014 | 21,534,014 |
CONDENSED STATEMENTS OF CASH FL
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
OPERATING ACTIVITIES | ||
Net loss | $ (1,135) | $ (1,117) |
Changes in operating assets and liabilities: | ||
Receivable from controlling stockholder | 685 | |
Accrued liabilities | 365 | 432 |
Controlling stockholder payable | 770 | |
Net cash provided by operating activities | ||
Net cash provided by investing activities | ||
Net cash provided by financing activities | ||
NET CHANGE IN CASH AND CASH EQUIVALENTS | ||
CASH AND CASH EQUIVALENTS, Beginning of period | ||
CASH AND CASH EQUIVALENTS, End of period |
ORGANIZATION AND SUMMARY OF SIG
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Mar. 31, 2020 | |
Accounting Policies [Abstract] | |
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation Organization Use of Estimates Going Concern Subsequent Events |
CONTROLLING STOCKHOLDER PAYABLE
CONTROLLING STOCKHOLDER PAYABLE | 3 Months Ended |
Mar. 31, 2020 | |
Related Party Transactions [Abstract] | |
CONTROLLING STOCKHOLDER PAYABLE | 2. CONTROLLING STOCKHOLDER PAYABLE As of March 31, 2020, the Company has a payable of $770 to its controlling stockholder related to advances to fund operations. The amount is non-interest bearing and payable on demand. |
ORGANIZATION AND SUMMARY OF S_2
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Mar. 31, 2020 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation |
Organization | Organization |
Use of Estimates | Use of Estimates |
Going Concern | Going Concern |
Subsequent Events | Subsequent Events |
ORGANIZATION AND SUMMARY OF S_3
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) | 3 Months Ended |
Mar. 31, 2020 | |
Accounting Policies [Abstract] | |
Date of incorporated | May 20, 2013 |
CONTROLLING STOCKHOLDER PAYAB_2
CONTROLLING STOCKHOLDER PAYABLE (Details Narrative) | Mar. 31, 2020USD ($) |
Related Party Transactions [Abstract] | |
Receivable from controlling stockholder | $ 770 |